טוען...

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

BACKGROUND: Breast cancer tumor markers are used by some clinicians to screen for disease recurrence risk. Since there is limited evidence of benefit, additional research may be warranted. AIM: To assess the potential value of a randomized clinical trial of breast tumor marker testing in routine fol...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Thariani, Rahber, Henry, Norah Lynn, Ramsey, Scott D, Blough, David K, Barlow, Bill, Gralow, Julie R, Veenstra, David L
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4018420/
https://ncbi.nlm.nih.gov/pubmed/24236631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cer.13.15
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!